Hematopoietic Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationGraft vs Host DiseaseMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeMelphalanCombined Modality TherapyStem CellsRemission InductionLymphoma, Non-HodgkinHematologic NeoplasmsLymphomaBone Marrow TransplantationMyeloablative AgonistsRecurrenceSalvage TherapyDisease-Free SurvivalHodgkin DiseaseCyclophosphamideTransplantation ChimeraBusulfanSurvival RateSurvival AnalysisEtoposideRetrospective StudiesHematopoietic Stem Cell MobilizationCytarabineLymphoma, FollicularGraft SurvivalTissue DonorsWhole-Body IrradiationVincristineHematopoietic Stem CellsGraft vs Leukemia EffectAntibodies, Monoclonal, Murine-DerivedLymphoma, B-CellPrognosisCarmustineVidarabineLiver TransplantationLymphoma, Mantle-CellLeukemia, Myeloid, AcuteLymphoma, Large B-Cell, DiffuseGraft vs Tumor EffectFollow-Up StudiesHistocompatibility TestingNeoplasm, ResidualCord Blood Stem Cell TransplantationTime FactorsAntigens, CD34ThiotepaImmunosuppressive AgentsLeukemiaBone Marrow PurgingAntineoplastic AgentsMesenchymal Stem Cell TransplantationDoxorubicinMyelodysplastic SyndromesLymphocyte TransfusionGranulocyte Colony-Stimulating FactorCell TransplantationPrednisoneAmyloidosisHistocompatibilitySiblingsPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, T-Cell, PeripheralKidney TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytomegalovirus InfectionsEmbryonic Stem CellsBoronic AcidsDexamethasoneT-LymphocytesAntineoplastic Agents, AlkylatingLymphocyte DepletionAntilymphocyte SerumPyrazinesLeukapheresisMinor Histocompatibility AntigensAntibodies, MonoclonalHepatic Veno-Occlusive DiseaseAdult Stem CellsChimerismAcute DiseaseThalidomideVirus ActivationIfosfamideLeukemia, MyeloidAutograftsProspective StudiesFatal OutcomeLymphoma, T-CellHematologic DiseasesHLA Antigens